Skip to Main Content

Paper Details

A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis.
Expert Rev Gastroenterol Hepatol
1
2023
Author NameAffiliation
Jean-Frederic ColombelIcahn School of Medicine at Mount Sinai
  • 1 - 1

Datasets

Release 1.2